130 related articles for article (PubMed ID: 36272185)
41. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein.
Hebecker M; Józsi M
J Biol Chem; 2012 Jun; 287(23):19528-36. PubMed ID: 22518841
[TBL] [Abstract][Full Text] [Related]
42. The inhibitory effect of factor J on the alternative complement pathway.
González-Rubio C; Jiménez-Clavero MA; Fontán G; López-Trascasa M
J Biol Chem; 1994 Oct; 269(42):26017-24. PubMed ID: 7929312
[TBL] [Abstract][Full Text] [Related]
43. Complement factor D in age-related macular degeneration.
Stanton CM; Yates JR; den Hollander AI; Seddon JM; Swaroop A; Stambolian D; Fauser S; Hoyng C; Yu Y; Atsuhiro K; Branham K; Othman M; Chen W; Kortvely E; Chalmers K; Hayward C; Moore AT; Dhillon B; Ueffing M; Wright AF
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8828-34. PubMed ID: 22003108
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.
Suankratay C; Mold C; Zhang Y; Lint TF; Gewurz H
Clin Exp Immunol; 1999 Sep; 117(3):442-8. PubMed ID: 10469045
[TBL] [Abstract][Full Text] [Related]
45. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
Harris CL; Pettigrew DM; Lea SM; Morgan BP
J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
[TBL] [Abstract][Full Text] [Related]
46. Activation of factor B of the complement system by kallikrein and its light chain.
Hiemstra PS; Daha MR; Bouma BN
Thromb Res; 1985 Jun; 38(5):491-503. PubMed ID: 3848216
[TBL] [Abstract][Full Text] [Related]
47. Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D.
González-Rubio C; González-Muñiz R; Jiménez-Clavero MA; Fontán G; López-Trascasa M
Biochim Biophys Acta; 1996 Jul; 1295(2):174-8. PubMed ID: 8695643
[TBL] [Abstract][Full Text] [Related]
48. Mutational analysis of the substrate binding site of human complement factor D.
Kim S; Narayana SV; Volanakis JE
Biochemistry; 1994 Dec; 33(48):14393-9. PubMed ID: 7981199
[TBL] [Abstract][Full Text] [Related]
49. Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H.
Devine DV; Rosse WF
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5873-7. PubMed ID: 2956607
[TBL] [Abstract][Full Text] [Related]
50. Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.
Schmidt CQ; Harder MJ; Nichols EM; Hebecker M; Anliker M; Höchsmann B; Simmet T; Csincsi ÁI; Uzonyi B; Pappworth IY; Ricklin D; Lambris JD; Schrezenmeier H; Józsi M; Marchbank KJ
Immunobiology; 2016 Apr; 221(4):503-11. PubMed ID: 26792457
[TBL] [Abstract][Full Text] [Related]
51. Discovery of 4-((2
Mainolfi N; Ehara T; Karki RG; Anderson K; Mac Sweeney A; Liao SM; Argikar UA; Jendza K; Zhang C; Powers J; Klosowski DW; Crowley M; Kawanami T; Ding J; April M; Forster C; Serrano-Wu M; Capparelli M; Ramqaj R; Solovay C; Cumin F; Smith TM; Ferrara L; Lee W; Long D; Prentiss M; De Erkenez A; Yang L; Liu F; Sellner H; Sirockin F; Valeur E; Erbel P; Ostermeier D; Ramage P; Gerhartz B; Schubart A; Flohr S; Gradoux N; Feifel R; Vogg B; Wiesmann C; Maibaum J; Eder J; Sedrani R; Harrison RA; Mogi M; Jaffee BD; Adams CM
J Med Chem; 2020 Jun; 63(11):5697-5722. PubMed ID: 32073845
[TBL] [Abstract][Full Text] [Related]
52. Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors.
Vulpetti A; Randl S; Rüdisser S; Ostermann N; Erbel P; Mac Sweeney A; Zoller T; Salem B; Gerhartz B; Cumin F; Hommel U; Dalvit C; Lorthiois E; Maibaum J
J Med Chem; 2017 Mar; 60(5):1946-1958. PubMed ID: 28157311
[TBL] [Abstract][Full Text] [Related]
53. Regulation of the alternative pathway of complement by pH.
Fishelson Z; Horstmann RD; Müller-Eberhard HJ
J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
[TBL] [Abstract][Full Text] [Related]
54. Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.
Michelfelder S; Parsons J; Bohlender LL; Hoernstein SNW; Niederkrüger H; Busch A; Krieghoff N; Koch J; Fode B; Schaaf A; Frischmuth T; Pohl M; Zipfel PF; Reski R; Decker EL; Häffner K
J Am Soc Nephrol; 2017 May; 28(5):1462-1474. PubMed ID: 27932477
[TBL] [Abstract][Full Text] [Related]
55. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
[TBL] [Abstract][Full Text] [Related]
56. Complement factor D-like activity of Porphyromonas gingivalis W83.
Schenkein HA
Oral Microbiol Immunol; 1991 Aug; 6(4):216-20. PubMed ID: 1667434
[TBL] [Abstract][Full Text] [Related]
57. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
Ruseva MM; Takahashi M; Fujita T; Pickering MC
Clin Exp Immunol; 2014 Apr; 176(1):84-92. PubMed ID: 24279761
[TBL] [Abstract][Full Text] [Related]
58. Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.
Zhang Y; Kremsdorf RA; Sperati CJ; Henriksen KJ; Mori M; Goodfellow RX; Pitcher GR; Benson CL; Borsa NG; Taylor RP; Nester CM; Smith RJH
Kidney Int; 2020 Nov; 98(5):1265-1274. PubMed ID: 32540405
[TBL] [Abstract][Full Text] [Related]
59. Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis.
Turner NA; Moake J
PLoS One; 2013; 8(3):e59372. PubMed ID: 23555663
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of complement alternative pathway in mice with Fab antibody to recombinant adipsin/factor D.
Pascual M; Catana E; White T; Spiegelman BM; Schifferli JA
Eur J Immunol; 1993 Jun; 23(6):1389-92. PubMed ID: 8500532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
